Kolexia
Rasigade Jean-Philippe
Biologie médicale
Centre d'addictologie de l'Hôpital de la Croix-Rousse
Lyon, France
97 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à staphylocoques Sepsie Tuberculose Sepsis néonatal Infection croisée Infections communautaires Pneumopathie infectieuse Tuberculose multirésistante Endocardite

Industries

MSD
3 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

The fitness cost of horizontally transferred and mutational antimicrobial resistance in .
Frontiers in microbiology   30 juin 2023
Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   17 mai 2023
Targeted proteomics links virulence factor expression with clinical severity in staphylococcal pneumonia.
Frontiers in cellular and infection microbiology   03 avril 2023
Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers.
Scientific reports   17 novembre 2022
Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   08 octobre 2022
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis.
Nature communications   30 août 2022
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Genome medicine   22 août 2022
Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
The Journal of antimicrobial chemotherapy   01 avril 2022
Prognostic factors of severe community-acquired staphylococcal pneumonia in France.
The European respiratory journal   11 novembre 2021
Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network.
The Journal of hospital infection   26 mai 2021